Advertisement

Electroconvulsive Therapy

  • Ali Ahsan Ali
  • Garima Garg
  • Deena J. Tampi
  • Rajesh R. Tampi
Chapter

Abstract

Psychiatric disorders are associated with significant morbidity and mortality among older adults. Electroconvulsive therapy (ECT) is a well-studied treatment among older adults with psychiatric disorders. ECT has been found to be effective and safe for use among older adults with mood disorders, psychotic disorders, and behavioral disturbances in dementia, catatonia, neuroleptic malignant syndrome, and Parkinson’s disease. In this chapter, we discuss the use of ECT among older adults with psychiatric disorders.

Keywords

Electroconvulsive therapy Bitemporal Right unilateral Bifrontal Depression Catatonia 

References

  1. 1.
    Mental health and older adults. Word Health Organization. 2016. http://www.who.int/mediacentre/factsheets/fs381/en/. Accessed 19 Dec 2016.
  2. 2.
    Fink M. A clinician-researcher and ECDEU: 1959–1980. In: Ban T, et al., editors. The triumph of psychopharmacology and the story of CINP. Budapest: Animula; 2000. p. 82–92.Google Scholar
  3. 3.
    Aperia B, Bergman H, Engelbrektson K, et al. Effects of electroconvulsive therapy on neuropsychological function and circulating levels of ACTH, cortisol, prolactin, and TSH in patients with major depressive illness. Acta Psychiatr Scand. 1985;72:536–41.CrossRefPubMedGoogle Scholar
  4. 4.
    Glue P, Costello J, Pert A, et al. Regional neurotransmitter responses after acute and chronic electroconvulsive shock. Psychopharmacology. 1990;100:60–5.CrossRefPubMedGoogle Scholar
  5. 5.
    Lerer B. Electroconvulsive shock and neurotransmitter receptors: implications for mechanisms of action and adverse effects of electroconvulsive therapy. Biol Psychiatry. 1984;19:361–83.PubMedGoogle Scholar
  6. 6.
    McCall WV, Andrade C, Sienaert P. Searching for the mechanism(s) of ECT’s therapeutic effect. J ECT. 2014;30(2):87–9.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Coffery CE, Kellner CH. Electroconvulsive therapy. In: Coffey CE, Cumming JL, editors. The American psychiatric press textbook of geriatric neuropsychiatry. 2nd ed. Washington, DC: American Psychiatric Press, Inc; 2000. p. 829–60.Google Scholar
  8. 8.
    Weiner RD, Krystal AD. Chapter 5: Electroconvulsive therapy. In: Blazer DG, Steffens DC, Busse EW, editors. The American Psychiatric Publishing textbook of geriatric psychiatry. 3rd ed. Washington, DC: American Psychiatric Press, Inc; 2004.Google Scholar
  9. 9.
    Kerner N, Prudic J. Current electroconvulsive therapy practice and research in the geriatric population. Neuropsychiatry (London). 2014;4(1):33–54.CrossRefGoogle Scholar
  10. 10.
    Dybedal GS, Bjolseth TM, Benth JS, Tanum L. Cognitive effects of Bifrontal versus right unilateral electroconvulsive therapy in the treatment of major depression in elderly patients: a randomized controlled trial. J ECT. 2016;32:151–8.CrossRefPubMedGoogle Scholar
  11. 11.
    Sackeim HA, Prudic J, Devanand DP, et al. A prospective, randomized, double-blind comparison of bilateral and right unilateral electroconvulsive therapy at different stimulus intensities. Arch Gen Psychiatry. 2000;57:425–34.CrossRefPubMedGoogle Scholar
  12. 12.
    Kellner CH, Husain MM, Knapp RG, et al. Right unilateral ultrabrief pulse ECT in geriatric depression: phase 1 of the PRIDE study. Am J Psychiatry. 2016;173:1101–9.CrossRefPubMedGoogle Scholar
  13. 13.
    Sackeim HA, Prudic J, Nobler MS, Fitzsimons L, Lisanby SH, Payne N, et al. Effects of pulse width and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy. Brain Stimul. 2008;1(2):71–83.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Sackheim HA. The use of electroconvulsive therapy in late-life depression. In: Salzman C, editor. Geriatric psychopharmacology. 3rd ed. Baltimore, MD: Williams & Wilkins; 2004. p. 385–422.Google Scholar
  15. 15.
    McDonald W. Neuromodulation treatments for geriatric mood and cognitive disorders. Am J Geriatr Psychiatry. 2016;24:1130–41.CrossRefPubMedGoogle Scholar
  16. 16.
    Tripathi P. Anesthetic management for ECT. In: Barnett SR, editor. Manual of geriatric anesthesia. New York, NY: Springer; 2013. p. 293–303.CrossRefGoogle Scholar
  17. 17.
    Weiner R. American Psychiatric Association Committee on electroconvulsive therapy. Practice of electroconvulsive therapy recommendations for treatment, training and privileging: a task force report of the American Psychiatric Association. 2nd ed. Washington, DC: American Psychiatric Association; 2001.Google Scholar
  18. 18.
    Sackeim HA, Decina P, Portnoy S, Neeley P, Malitz S. Studies of dosage, seizure threshold, and seizure duration in ECT. Biol Psychiatry. 1987;22(3):249–68.CrossRefPubMedGoogle Scholar
  19. 19.
    Hooten WM, Rasmussen KG Jr. Effects of general anesthetic agents in adults receiving electroconvulsive therapy: a systematic review. J ECT. 2008;24:208–23.CrossRefPubMedGoogle Scholar
  20. 20.
    Akcaboy ZN, Akcaboy EY, Yigitbasł B, et al. Effects of remifentanil and alfentanil on seizure duration, stimulus amplitudes and recovery parameters during ECT. Acta Anaesthesiol Scand. 2005;49:1068–71.CrossRefPubMedGoogle Scholar
  21. 21.
    Krystal AD, Weiner RD, Dean MD, et al. Comparison of seizure duration, ictal EEG, and cognitive effects of ketamine and methohexital anesthesia with ECT. J Neuropsychiatry Clin Neurosci. 2003;15(1):27–34.CrossRefPubMedGoogle Scholar
  22. 22.
    Khalid N, Atkins M, Kirov G. The effects of etomidate on seizure duration and electrical stimulus dose in seizure-resistant patients during electroconvulsive therapy. J ECT. 2006;22(3):184–8.CrossRefPubMedGoogle Scholar
  23. 23.
    Bailine SH, Petrides G, Doft M, Lui G. Indications for the use of propofol in electroconvulsive therapy. J ECT. 2003;19(3):129–32.CrossRefPubMedGoogle Scholar
  24. 24.
    Bauer J, Hageman I, Dam H, et al. Comparison of propofol and thiopental as anesthetic agents for electroconvulsive therapy: a randomized, blinded comparison of seizure duration, stimulus charge, clinical effect, and cognitive side effects. J ECT. 2009;25(2):85–90.CrossRefPubMedGoogle Scholar
  25. 25.
    Martin BA, Cooper RM, Parikh SV. Propofol anesthesia, seizure duration, and ECT: a case report and literature review. J ECT. 1998;14(2):99–108.CrossRefPubMedGoogle Scholar
  26. 26.
    Saito S, Kadoi Y, Nara T, et al. The comparative effects of propofol versus thiopental on middle cerebral artery blood flow velocity during electroconvulsive therapy. Anesth Analg. 2000;91:1531–6.CrossRefPubMedGoogle Scholar
  27. 27.
    Singh PM, Arora S, Borle A, Varma P, Trikha A, Goudra BG. Evaluation of etomidate for seizure duration in electroconvulsive therapy: a systematic review and meta-analysis. J ECT. 2015;31(4):213–25.CrossRefPubMedGoogle Scholar
  28. 28.
    Gazdag G, Kocsis N, Tolna J, Iványi Z. Etomidate versus propofol for electroconvulsive therapy in patients with schizophrenia. J ECT. 2004;20(4):225–9.CrossRefPubMedGoogle Scholar
  29. 29.
    Ingram A, Schweitzer I, Ng CH, Saling MM, Savage G. A comparison of propofol and thiopentone use in electroconvulsive therapy: cognitive and efficacy effects. J ECT. 2007;23(3):158–62.CrossRefPubMedGoogle Scholar
  30. 30.
    Kellner CH, Husain MM, Knapp RG, et al. A novel strategy for continuation ECT in geriatric depression: phase 2 of the PRIDE study. Am J Psychiatry. 2016;173:1110–8.CrossRefPubMedGoogle Scholar
  31. 31.
    Gill S, Bronskill S, Normand S, et al. Antipsychotic drug use and mortality in older adults with dementia. Ann Intern Med. 2007;146:775–86.CrossRefPubMedGoogle Scholar
  32. 32.
    Wojcinska AA, Swiecicki L. The efficacy and safety of ECT in population before and after 60 years of age. Psychiatr Pol. 2016;50(5):1015–26.CrossRefGoogle Scholar
  33. 33.
    McDonald IM, Perkins M, Marjerrison G, et al. Controlled comparison of amitriptyline and electroconvulsive therapy in the treatment of depression. BJP. 1966;122(12):1427–31.Google Scholar
  34. 34.
    Nemeroff CB, Evans DL, Gyulai L, et al. Double blind, placebo controlled comparison of imipramine and paroxetine in the treatment of bipolar depression. Am J Psychiatry. 2001;158(6):906–12.CrossRefPubMedGoogle Scholar
  35. 35.
    Aziz R, Lorberg B, Tampi RR. Treatments of late life bipolar disorder. Am J Geriatr Pharmacother. 2006;4(4):347–64.CrossRefPubMedGoogle Scholar
  36. 36.
    O’Connor MK, Knapp R, Husain MM, et al. The influence of age on the response of major depression to electroconvulsive therapy: a CORE report. Am J Psychiatry. 2001;9:382–90.Google Scholar
  37. 37.
    Tew JD, Mulsant BH, Haskett RF, et al. Acute efficacy of ECT in the treatment of major depression in the old-old. Am J Psychiatry. 1999;156:1865–70.PubMedGoogle Scholar
  38. 38.
    Spaans HP, Sienaert P, Bouckaert F, et al. Speed of remission in elderly patients with depression: electroconvulsive therapy v. medication. Br J Psychiatry. 2015;206:67–71.CrossRefPubMedGoogle Scholar
  39. 39.
    Petrides G, Fink M, Husain MM, et al. ECT remission rates in psychotic versus nonpsychotic depressed patients: a report from CORE. J ECT. 2001;17(4):244–53.CrossRefPubMedGoogle Scholar
  40. 40.
    Gijsman HJ, Geddes JR, Rendell JM, et al. Antidepressants for bipolar depression: a systematic review of randomized, controlled trials. Am J Psychiatry. 2004;161(9):1537–47.CrossRefPubMedGoogle Scholar
  41. 41.
    Daly JJ, Prudic J, Devanand DP, et al. ECT in bipolar and unipolar depression: differences in speed of response. Bipolar Disord. 2001;3:95–104.CrossRefPubMedGoogle Scholar
  42. 42.
    Agarkar S, Hurt S, Lisanby S, et al. ECT use in unipolar and bipolar depression. J ECT. 2012;28:e39–40.CrossRefPubMedPubMedCentralGoogle Scholar
  43. 43.
    Sienaert P, Vansteelandt K, Demyttenaere K, et al. Ultrabrief pulse ECT in bipolar and unipolar depressive disorder: differences in speed of response. Bipolar Disord. 2009;11(4):418–24.CrossRefPubMedGoogle Scholar
  44. 44.
    Bailine S, Fink M, Knapp R, et al. Electroconvulsive therapy is equally effective in unipolar and bipolar depression. Acta Psychiatr Scand. 2010;121(6):431–6.CrossRefPubMedGoogle Scholar
  45. 45.
    Grunhaus L, Schreiber S, Dolberg OT, et al. Response to ECT in major depression: are there differences between unipolar and bipolar depression? Bipolar Disord. 2002;4(1):91–3.CrossRefPubMedGoogle Scholar
  46. 46.
    Dierckx B, Heijnen WT, van den Broek WW, Birkenhager TK. Efficacy of electroconvulsive therapy in bipolar versus unipolar major depression: a meta-analysis. Bipolar Disord. 2012;14:146–50.CrossRefPubMedGoogle Scholar
  47. 47.
    Mukherjee S, Sackheim HA, Schnur DB. Electroconvulsive therapy of acute manic episodes: a review of 50 years’ experience. Am J Psychiatry. 1994;151:169–76.CrossRefPubMedGoogle Scholar
  48. 48.
    Small JG, Klapper MH, Kellams JJ, et al. Electroconvulsive treatment compared with lithium in the management of manic states. Arch Gen Psychiatry. 1988;45(8):727–32.CrossRefPubMedGoogle Scholar
  49. 49.
    Salzman C. Clinical geriatric psychopharmacology. 4th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2005.Google Scholar
  50. 50.
    Damm J, Eser D, Schüle C, et al. Influence of age on effectiveness and tolerability of electroconvulsive therapy. J ECT. 2010;26(4):282–8.CrossRefPubMedGoogle Scholar
  51. 51.
    Liu AY, Rajji TK, Blumberger DM, Daskalakis ZJ, Mulsant BH. Brain stimulation in the treatment of late-life severe mental illness other than unipolar nonpsychotic depression. Am J Geriatr Psychiatry. 2014;22(3):216–40.CrossRefPubMedGoogle Scholar
  52. 52.
    Kramer BA. ECT in elderly patients with schizophrenia. Am J Geriatr Psychiatry. 1999;7(2):171–4.CrossRefPubMedGoogle Scholar
  53. 53.
    Botteron K, Figiel GS, Zorumski CF. Electroconvulsive therapy in patients with late-onset psychoses and structural brain changes. J Geriatr Psychiatry Neurol. 1991;4:44–7.PubMedGoogle Scholar
  54. 54.
    Figiel GS, Botteron K, Zorumski CF, et al. The treatment of late age onset psychoses with electroconvulsive therapy. Int J Geriatr Psychiatry. 1992;7:183–9.CrossRefGoogle Scholar
  55. 55.
    Howard R, Rabins P, Seeman M, et al. Late-onset schizophrenia and very-late-onset schizophrenia like psychosis: an international consensus. The international late-onset schizophrenia group. Am J Psychiatry. 2000;157:172–8.CrossRefPubMedGoogle Scholar
  56. 56.
    American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-5. Washington, DC: American Psychiatric Association; 2013.CrossRefGoogle Scholar
  57. 57.
    Aloysi AS, Popeo DM, Kellner CH. Cases of catatonia on an academic electroconvulsive therapy service: lessons to learn. J ECT. 2011;27(3):259–61.CrossRefPubMedGoogle Scholar
  58. 58.
    Hatta K, Miyakawa K, Ota T, Usui C, Nakamura H, Arai H. Maximal response to electroconvulsive therapy for the treatment of catatonic symptoms. J ECT. 2007;23(4):233–5.CrossRefPubMedGoogle Scholar
  59. 59.
    Bush G, Fink M, Petrides G, et al. Catatonia II. Treatment with lorazepam and electroconvulsive therapy. Acta Psychiatr Scand. 1996;93:137–43.CrossRefPubMedGoogle Scholar
  60. 60.
    Hawkins J-M, Archer K-J, Strowski S-M, et al. Somatic treatment of catatonia. Int J Psychiatry Med. 1995;25:345–69.CrossRefPubMedGoogle Scholar
  61. 61.
    Suzuki K, Awata S, Matsuoka H. Short-term effect of ECT in middle-aged and elderly patients with intractable catatonic schizophrenia. J ECT. 2003;19:73–80.CrossRefPubMedGoogle Scholar
  62. 62.
    Suzuki K, Awata S, Matsuoka H. One-year outcome after response to ECT in middle-aged and elderly patients with intractable catatonic schizophrenia. J ECT. 2004;20:99–106.CrossRefPubMedGoogle Scholar
  63. 63.
    Suzuki K, Awata S, Takano T, et al. Adjusting the frequency of continuation and maintenance electroconvulsive therapy to prevent relapse of catatonic schizophrenia in middle-aged and elderly patients who are relapse-prone. Psychiatry Clin Neurosci. 2006;60(4):486–92.CrossRefPubMedGoogle Scholar
  64. 64.
    Suzuki K, Awata S, Takano T, et al. Continuation electroconvulsive therapy for relapse prevention in middle-aged and elderly patients with intractable catatonic schizophrenia. Psychiatry Clin Neurosci. 2005;59:481–9.CrossRefPubMedGoogle Scholar
  65. 65.
    Rohland BM, Carroll BT, Jacoby RG. ECT in the treatment of the catatonic syndrome. J Affect Disord. 1993;29:255–61.CrossRefPubMedGoogle Scholar
  66. 66.
    Lindsey PL. Psychotropic medication use among older adults: what all nurses need to know. J Gerontol Nurs. 2009;35:28–38.CrossRefPubMedPubMedCentralGoogle Scholar
  67. 67.
    Oruch R, Pryme IF, Engelsen BA, Lund A. Neuroleptic malignant syndrome: an easily overlooked neurologic emergency. Neuropsychiatr Dis Treat. 2017;13:161–75.CrossRefPubMedPubMedCentralGoogle Scholar
  68. 68.
    Carroll BT. Catatonia on the consultation-liaison service. Psychosomatics. 1992;33:310–5.CrossRefPubMedGoogle Scholar
  69. 69.
    Trollor JN, Sachdev PS. Electroconvulsive treatment of neuroleptic malignant syndrome: a review and report of cases. Aust N Z J Psychiatry. 1999;33(5):650–9.CrossRefPubMedGoogle Scholar
  70. 70.
    Scheftner WA, Shulman RB. Treatment choice in neuroleptic malignant syndrome. Convuls Ther. 1992;8:267–79.PubMedGoogle Scholar
  71. 71.
    International Psychogeriatric Association. Behavioral and psychological symptoms of dementia (BPSD): a clinical and research update. Int Psychogeriatr. 2000;12(Suppl 1):1–424.Google Scholar
  72. 72.
    Tariot PN. Treatment of agitation in dementia. J Clin Psychiatry. 1999;60(Suppl 8):11–20.PubMedGoogle Scholar
  73. 73.
    Seitz DP, Adunuri N, Gill SS, Gruneir A, Herrmann N, Rochon P. Antidepressants for agitation and psychosis in dementia. Cochrane Database Syst Rev. 2011;16(2):CD008191.Google Scholar
  74. 74.
    Sink KM, Holden KF, Yaffe K. Pharmacological treatment of neuropsychiatric symptoms of dementia: a review of the evidence. JAMA. 2005;293(5):596–608.CrossRefPubMedGoogle Scholar
  75. 75.
    Lenzer J. FDA warns about using antipsychotic drugs for dementia. BMJ. 2005;330(7497):922.PubMedPubMedCentralGoogle Scholar
  76. 76.
    Grant JE, Mohan SN. Treatment of agitation and aggression in four demented patients using ECT. J ECT. 2001;17(3):205–9.CrossRefPubMedGoogle Scholar
  77. 77.
    Ujkaj M, Davidoff DA, Seiner SJ, Ellison JM, Harper DG, Forester BP. Safety and efficacy of electroconvulsive therapy for the treatment of agitation and aggression in patients with dementia. Am J Geriatr Psychiatry. 2012;20(1):61–72.CrossRefPubMedGoogle Scholar
  78. 78.
    Acharya D, Harper DG, Achtyes ED, et al. Safety and utility of acute electroconvulsive therapy for agitation and aggression in dementia. Int J Geriatr Psychiatry. 2015;30(3):265–73.CrossRefPubMedGoogle Scholar
  79. 79.
    Reijnders JS, Ehrt U, Weber WE, Aarsland D, Leentjens AF. A systematic review of prevalence studies of depression in Parkinson’s disease. Mov Disord. 2008;23(2):183–9.CrossRefPubMedGoogle Scholar
  80. 80.
    Fregni F, Simon DK, Wu A, Pascual-Leone A. Non-invasive brain stimulation for Parkinson’s disease: a systematic review and meta-analysis of the literature. J Neurol Neurosurg Psychiatry. 2005;76(12):1614–23.CrossRefPubMedPubMedCentralGoogle Scholar
  81. 81.
    Kennedy R, Mittal D, O’Jile J. Electroconvulsive therapy in movement disorders: an update. J Neuropsychiatry Clin Neurosci. 2003;15:407–21.CrossRefPubMedGoogle Scholar
  82. 82.
    McDonald WM, Meeks WT, McCall WV, Zorumski CF. Electroconvulsive therapy. In: Schatzberg AF, Nemeroff CB, editors. The American Psychiatric Publishing textbook of psychopharmacology. 4th ed. Arlington, VA: American Psychiatric Publishing; 2009.Google Scholar
  83. 83.
    Cusin C, Franco FB, Fernandez-Robles C, DuBois CM, Welch CA. Rapid improvement of depression and psychotic symptoms in Huntington’s disease: a retrospective chart review of seven patients treated with electroconvulsive therapy. Gen Hosp Psychiatry. 2013;35(6):678.e3–5.CrossRefGoogle Scholar
  84. 84.
    Reti IM, Krishnan A, Podlisky A, et al. Predictors of electroconvulsive therapy postictal delirium. Psychosomatics. 2014;55(3):272–9.CrossRefPubMedGoogle Scholar
  85. 85.
    Sobin C, Sackeim HA, Prudic J, et al. Predictors of retrograde amnesia following ECT. Am J Psychiatry. 1995;152:995–1001.CrossRefPubMedGoogle Scholar
  86. 86.
    Stoudemire A, Knos G, Gladson M, et al. Labetalol in the control of cardiovascular responses to electroconvulsive therapy in high-risk depressed medical patients. J Clin Psychiatry. 1990;51:508–12.PubMedGoogle Scholar
  87. 87.
    Ciraulo D, Lind L, Salzman C, et al. Sodium nitroprusside treatment of ECT-induced blood pressure elevations. Am J Psychiatry. 1978;135:1105–6.CrossRefPubMedGoogle Scholar
  88. 88.
    Wajima Z, Yoshikawa T, Ogura A, et al. Intravenous verapamil blunts hyperdynamic responses during electroconvulsive therapy without altering seizure activity. Anesth Analg. 2002;95:400–2.PubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Ali Ahsan Ali
    • 1
  • Garima Garg
    • 2
    • 3
  • Deena J. Tampi
    • 4
  • Rajesh R. Tampi
    • 2
    • 3
  1. 1.Ican School of Medicine at Mount Sinai (Elmhurst)QueensUSA
  2. 2.Case Western Reserve University School of MedicineClevelandUSA
  3. 3.MetrohealthClevelandUSA
  4. 4.Diamond HealthcareRichmondUSA

Personalised recommendations